Tectonic Therapeutic Inc (TECX)

Currency in USD
31.165
+1.385(+4.65%)
Closed·
31.160-0.005(-0.02%)
·
TECX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
29.50031.860
52 wk Range
14.38536.030
Key Statistics
Prev. Close
29.78
Open
29.93
Day's Range
29.5-31.86
52 wk Range
14.385-36.03
Volume
336.47K
Average Volume (3m)
257.4K
1-Year Change
44.8861%
Book Value / Share
12.27
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TECX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
78.444
Upside
+151.71%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Tectonic Therapeutic Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

10 Buy
0 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 78.444
(+151.71% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Raymond James
Buy81.00+159.91%76.00Upgrade26/05/2026
Stifel
Buy75.00+140.65%-New Coverage13/04/2026
Leerink Partners
Buy60.00+92.52%69.00Maintain25/02/2026
Oppenheimer
Buy80.00+156.70%-Maintain30/10/2025
Wells Fargo
Buy101.00+224.08%-New Coverage20/10/2025

Earnings

Latest Release
07/05/2026
EPS / Forecast
-1.34 / -1.65
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Compare TECX to Peers and Sector

Metrics to compare
TECX
Peers
Sector
Relationship
P/E Ratio
−7.1x−6.7x−0.5x
PEG Ratio
−1.280.040.00
Price/Book
2.6x3.3x2.6x
Price / LTM Sales
-2.7x3.1x
Upside (Analyst Target)
156.7%154.5%50.7%
Fair Value Upside
Unlock−10.8%7.6%Unlock

Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company’s lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
4.58M24.28%136.44M
Other Institutional Investors
12.74M67.53%379.44M
Public Companies & Retail Investors
1.55M8.19%46.05M
Total
18.87M100.00%561.92M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
FMR LLC14.88%2,807,34783,603
TCG Crossover Management, LLC6.20%1,169,76034,835

People Also Watch

11.050
QTTB
+7.18%
17.76
NRIX
+0.51%
136.69
ARCB
+2.18%
32.38
PRDO
-2.15%
16.18
MLKN
-1.82%

FAQ

What Is the Tectonic Therapeutic (NASDAQ: TECX) Share Price Today?

The Tectonic Therapeutic stock price today is 31.165 USD.

What Stock Exchange Does Tectonic Therapeutic (TECX) Trade On?

Tectonic Therapeutic is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Tectonic Therapeutic?

The stock symbol (also called a 'ticker') for Tectonic Therapeutic is "TECX."

What Is the Current Tectonic Therapeutic Market Capitalisation?

As of today, Tectonic Therapeutic (NASDAQ: TECX) market cap is 589.660M USD.

What Is Tectonic Therapeutic's (TECX) Earnings Per Share (TTM)?

The Tectonic Therapeutic EPS is currently -4.458 (Trailing Twelve Months).

When Is the Next Tectonic Therapeutic Earnings Date?

Tectonic Therapeutic's next earnings report will be released on 19/08/2026.

Is TECX a Buy or Sell From a Technical Analyst Perspective?

Based on today's Tectonic Therapeutic moving averages and other technical indicators, the daily buy/sell signal for TECX stock is Strong Buy.

How Many Times Has Tectonic Therapeutic Stock Split?

Tectonic Therapeutic has split 1 times. (See the TECX stock split history page for full effective split date and price information.)

How Many Employees Does Tectonic Therapeutic Have?

Tectonic Therapeutic has 60 employees, based on their latest Companies House report.

What is the current trading status of Tectonic Therapeutic (NASDAQ: TECX)?

As of 30/05/2026, Tectonic Therapeutic (TECX) is trading at a share price of 31.165 USD, with a previous close of 29.780 USD. The stock has fluctuated within a day range of 29.500 USD to 31.860 USD, while its 52-week range spans from 14.385 USD to 36.030 USD.

What Is Tectonic Therapeutic (TECX) Price Target According to Analysts?

The average 12-month price target for Tectonic Therapeutic is 78.444 USD, with a high estimate of 101 USD and a low estimate of 60 USD. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +151.71% Upside potential.

What Is the TECX After Hours Price?

TECX's last after hours stock price is 31.160 USD, the stock has decreased by -0.005, or -0.020%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.